Latest news with #Pennsylvania
The Guardian
15 minutes ago
- Politics
- The Guardian
Emil Bove judge confirmation moves step closer despite Democratic walkout
Republican senators on Thursday advanced through the judiciary committee Emil Bove's nomination to serve as a judge on a federal appeals court, after Democrats walked out of the session in protest of the GOP's refusal to call a whistleblower who alleged the nominee advocated for ignoring court orders. Donald Trump nominated Bove, his defense attorney who he appointed as a top justice department official in the early weeks of his new administration, for a seat on the third circuit court of appeals overseeing New Jersey, Pennsylvania, Delaware and the US Virgin Islands. Bove's advancement through the judiciary committee clears the way for his confirmation to be voted on by the full Senate. His nomination for the lifetime position has faced strident opposition from Democrats, after Erez Reuveni, a former justice department official who was fired from his post, alleged that during his time at the justice department, Bove told lawyers that they 'would need to consider telling the courts 'fuck you' and ignore any such court order' blocking efforts to remove immigrants to El Salvador. In testimony before the committee last month, Bove denied the accusation, and Reuveni later provided text messages that supported his claim. At Thursday's hearing, the New Jersey senator Cory Booker attempted to formally delay the vote on confirming Bove, citing Reuveni's whistleblower complaint as well as letters from state and federal prosecutors opposing his nomination. 'There is no need to vote on this nominee today. It is a false urgency,' Booker said. His request was rejected by the committee's Republican chair, Chuck Grassley, and Democratic senators then walked out as the committee voted on Bove's nomination. 'What are you afraid of about even debating this, putting things on the record, hearing from every senator? Dear God, that's what our obligations are,' said Booker, who remained in the committee's chambers and continued speaking as Republican senators called out their votes on Bove and other judicial nominees. 'This is outrageous that you're not allowing senators to have their fair say before a controversial nominee is being done. This is unbelievable. This is unjust. This is wrong. It is the further deterioration of this committee's integrity with a person like this. What are you afraid of?' In addition to the whistleblower complaint, Democrats have criticized Bove for his role, while serving as acting justice department deputy attorney general, in the firings of prosecutors who worked on cases connected to the January 6 insurrection, as well as for requesting a list of FBI agents who investigated the attack. He also oversaw legal motions to drop charges against the New York City mayor, Eric Adams, which prompted the resignation of seven veteran prosecutors in New York who refused to cooperate. Republicans showed little indication of sharing those concerns, and voted to advance Bove along with 11 other nominees to federal judgeships nationwide. Thom Tillis, a retiring Republican senator who in May derailed Trump's nomination of Ed Martin as the top federal prosecutor in Washington DC over his defense of January 6 insurrectionists, said he did not find credible Democrats' assertions that Bove had similar views. 'Does anybody really believe that if I was convinced that Bove had made any statements condoning the violent acts against Capitol police officers, that I'd be voting for him? Just ask Ed Martin whether or not that's a red line,' Tillis said.
Yahoo
16 minutes ago
- Sport
- Yahoo
Former NBA champion warns 76ers about Tyrese Maxey's future
The Philadelphia 76ers are in a tough position, and it might soon cost them. Last season, the 76ers were expected to be near the top of the Eastern Conference and competing for a spot in the NBA Finals. Instead, Joel Embiid missed the majority of the season, while Paul George and Tyrese Maxey each dealt with their own injuries, leading to the 76ers' demise. While the team was bad enough to get the No. 3 pick and take V.J. Edgecombe, there is still no clarity on the team's health and potential to bounce back. These recent developments have led many to criticize Daryl Morey and the 76ers as they move forward. One of those critics is former NBA champion and ESPN personality Kendrick Perkins. On Thursday's First Take, Perkins didn't hold back about the franchise's potentially grim future. 'They're on the clock when it comes down to Tyrese Maxey,' Perkins said. 'And when I say 'on the clock,' because if they keep trending in this direction of no culture and no stability, guess what? Tyrese Maxey is gonna want out of Philadelphia.' Those are strong words from one of the strongest personalities in NBA media, but he's likely correct. Considering how much power stars have in today's league, the 76ers need to prove to Maxey that they can compete on a consistent basis and have stars on the floor around him. As Embiid and George are both recovering from injuries, that isn't a guarantee the 76ers are in a position to make anytime soon. Philadelphia will be leaning heavily on Maxey next season to keep the team afloat in a wide-open Eastern Conference, but that load could be more than the young star guard wants to handle, and it could lead to his eventual exit, as Perkins said.
Yahoo
an hour ago
- Health
- Yahoo
Nonprofits ChristianaCare, Virtua Health explore merger
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Nonprofits ChristianaCare and Virtua Health on Wednesday signed a non-binding letter of intent to explore a merger between the northeastern health systems. The combined nonprofit regional system would span more than 600 sites of care and employ nearly 30,000 employees across 10 contiguous counties in New Jersey, Delaware, Pennsylvania and Maryland, according to a press release. If combined, annual revenues between the two systems could tally over $6 billion. Dive Insight: Virtua and ChristianaCare will enter the due diligence process with the intent to sign definitive agreements and seek regulatory approvals for the merger. Day-to-day operations will remain unchanged during negotiations and both organizations will remain separate entities while they explore a combination, the nonprofits said. 'We've reached an important stage. Both organizations are signaling the desire to continue a thorough and strategic exploration of what would be possible if we joined two legacies of health care excellence,' said Edward Cloues, chair of Virtua Health's board of trustees, in a statement. 'Our trustees are encouraged by our initial assessments and conversations which suggest we could collectively enhance our capabilities and strengthen our outreach to the communities who depend on us.' If merged, the health systems say they would create better access to urgent, primary and behavioral healthcare, including a 'proposed maternal risk program' to support more than 15,000 births per year, according to a press release. New Jersey-based Virtua Health's portfolio consists of five hospitals, two freestanding emergency departments and 42 ambulatory surgery centers. Delaware-based ChristianaCare has three hospitals and various outpatient services in northern Delaware and surrounding areas. Both nonprofit systems have teaching relationships. Virtua is affiliated with Rowan University and partners with Penn Medicine and Children's Hospital of Philadelphia for different specialties. ChristianaCare is a teaching system with more than 260 residents and fellows. The combined entity could have over $6 billion in annual revenues. Virtua Health recorded $3.2 billion in revenue for the year ended Dec. 31, 2024, while ChristianaCare reported operating revenues of $3.1 billion for the year ended June 30, 2024. Credit agencies have rated both systems as 'stable.' S&P Global in December said it expected Virtua to continue generating 'solid operating margins and cash flow.' In July, Moody's Ratings said ChristianaCare had ample liquidity and a strong state-wide brand with robust demand for its clinical services. The merger comes as providers face significant policy shifts. The newly-enacted Big Beautiful Bill Act includes over $1 trillion in cuts to the safety-net program Medicaid. Providers are expected to log significant losses. By 2034, more than 100 rural hospitals are estimated to be at high risk of closure. In 2024, 21% of Virtua's patient service revenue came from fee-for-service Medicare and Medicaid. More than 15% of ChristianaCare's net patient service revenues in its 2024 financial year came from Medicaid. 'Our vision for this new health system — when Medicare and Medicaid are facing cuts and many hospitals are struggling to stay open — gives me hope and excitement for our future and for the health of our neighbors,' George Foutrakis, chair of ChristianaCare's board of directors, said in a release. Recommended Reading Hospital, health system M&A falls in Q2 as Medicaid cuts loom: report Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Politics
- Yahoo
Senate Democrats walk out of committee vote to advance Trump court pick Emil Bove
Senate Judiciary Committee Democrats walked out before Republicans voted on Thursday to advance President Donald Trump's nomination of Emil Bove -- the controversial top Justice Department official who formerly served as Trump's defense attorney -- to a seat on the powerful Third Circuit U.S. Court of Appeals. The Democrats left before Republicans forced the vote for Bove's lifetime appointment on the appeals court that oversees districts in Delaware, New Jersey and Pennsylvania. Bove has repeatedly drawn criticism from Democrats in the opening six months of Trump's presidency for cultivating a reputation as one of President Trump's chief enforcers at DOJ. The Republican-controlled Senate Judiciary Committee's vote to advance Bove means he will next face a vote in the full Senate. MORE: Why do Trump's MAGA followers care so much about the Epstein files? Democratic Sen. Cory Booker spoke furiously from the dais, pleading with Senate Judiciary Committee Chair Chuck Grassley to allow further debate on Bove's nomination, but Grassley declined. "What are you afraid of about even debating this?" Booker asked Grassley. "Sir, with all appeals to your decency, with all appeals to your integrity, with all appeals to past jurisdictions and past precedent, why are you doing this?" Booker asked. More than 900 former Justice Department employees sent a letter to the Senate Judiciary Committee on Wednesday urging lawmakers to vote down Bove's nomination. He has fired scores of one-time career officials at Main Justice and the FBI, including prosecutors who worked on former special counsel Jack Smith's investigations of Trump as well as the Jan. 6 assault on the U.S. Capitol by a pro-Trump mob. Bove also was at the center of the department's controversial decision to drop the federal corruption case against New York Democratic Mayor Eric Adams, which led to the resignations of multiple prosecutors who argued the effort appeared to be a 'quid pro quo' to secure Adams' cooperation with the Trump administration's immigration enforcement actions. Adams and Bove have both denied any such "quid pro quo" arrangement, but in agreeing to drop the charges the federal judge overseeing Adams' case dinged the Justice Department writing, "Everything here smacks of a bargain." "Mr. Bove's trampling over institutional norms in this case, and in others, sent shockwaves through the ranks -- cratering morale, triggering mass departures, and eroding the effectiveness of DOJ's vital work," the prosecutors wrote of Bove's actions. "Prosecutorial authority carries profound consequences on individuals' lives and the integrity of our public institutions; wielding it without impartiality is a flagrant abuse of that power." MORE: Trump admin live updates More recently, however, Bove's actions have come under scrutiny as the subject of a whistleblower complaint by fired DOJ attorney Erez Reuveni, who has accused Bove and other top DOJ officials of repeatedly discussing how they could potentially disobey court orders that seek to restrict the Trump administration's immigration actions. Reuveni's complaint alleged that in one meeting Bove suggested saying "f--- you" to courts who may try to block deportations under the Alien Enemies Act. During his confirmation hearing, Bove disputed much of Reuveni's complaint -- though he only said he could "not recall" using such an expletive to describe their response to a court order. "Each one of the undersigned would testify, under oath, that we have never -- and would never -- tell a Justice Department attorney to consider defying a court order," the letter said. "Moreover, the Justice Department's later defiance of judicial mandates in the cases where Mr. Bove previewed doing so further suggests that disregarding court orders was Mr. Bove's intent all along." Republicans on the committee rushed to Bove's defense in the wake of the whistleblower complaint, and accused Reuveni of partnering with Democrats in seeking to tank Bove's nomination by filing it with the committee just 24 hours before he was set to appear publicly before them. Responding to the former DOJ officials' letter Wednesday, department official Brian Nieves attacked Justice Connection as a "political hit squad masquerading as a support network" and said "they certainly don't speak for DOJ." "They speak for a bitter faction angry they no longer call the shots," said Nieves, a deputy chief of staff to Deputy Attorney General Todd Blanche. "Their attacks on Emil Bove are dishonest, coordinated, and disgraceful."
Yahoo
an hour ago
- Health
- Yahoo
More than 67,000 cases of Power Stick deodorant recalled nationwide
More than 67,000 cases of Power Stick deodorants have been recalled for not meeting quality and safety standards. A.P. Deauville, a health and beauty product manufacturer in Pennsylvania, issued a recall for 67,214 cases of Power Stick roll-on deodorant on July 10. The products were recalled for cGMP deviations, which are deviations from established regulations outlined by the Food and Drug Administration (FDA)-enforced Current Good Manufacturing Practices. The recall does not specify a remedy for consumers or which regulations were missed. A.P. Deauville did not immediately respond for comment about the recall when contacted by USA TODAY on Thursday, July 17. What products are listed in the recall? Can't see the table in your browser? Visit Where were the recalled products sold? According to the recall, the Power Stick deodorants were sold nationwide. The deodorants are available for purchase from major retailers such as Walmart and Amazon. What to do with the recalled Power Stick deodorant? The FDA usually recommends discarding recalled products and contacting the manufacturer with any questions you may have. Greta Cross is a national trending reporter at USA TODAY. Story idea? Email her at gcross@ This article originally appeared on USA TODAY: More than 67,000 cases of Power Stick deodorant recalled
